Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

32 citing papers in PubMed.

1. CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers.Journal of clinical pharmacology · 2020
   Trial
2. The dis-economy of precision medicine: how stratification multiplies social tension in healthcare systems.Medicine, health care, and philosophy · 2026
   Article
3. Applications of Metabolomics in the Development of Biomedicine and Biotechnology.Advances in experimental medicine and biology · 2026
   Review
4. Pharmacoepigenetics in schizophrenia: Predicting drug response.World journal of psychiatry · 2025
   Review
5. Choosing the Right Vasoactive Agent in Acute Variceal Bleeding in Cirrhotic Patients: A Review of Terlipressin vs. Octreotide Outcomes.Cureus · 2025
   Review
6. Opioids in the Brazilian Healthcare Landscape: Crucial Analysis through Anvisa VigiMed Data and Pharmacogenetic Aspects.ACS omega · 2025
   Article
7. Pioneering pain management with botulinum toxin type A: From anti-inflammation to regenerative therapies.Heliyon · 2025
   Review
8. Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients.Genes · 2025
   Article
9. The role of inflammatory gene polymorphisms in severe COVID-19: a review.Virology journal · 2024
   Review
10. Allele frequency of genetic variations related to theJournal of diabetes and metabolic disorders · 2024
    Article
11. Trust your gut: Establishing confidence in gastrointestinal models - An overview of the state of the science and contexts of use.ALTEX · 2024
    Article
12. Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?The pharmacogenomics journal · 2023
    Review
13. Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.Biomedicines · 2022
    Review
14. Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
15. Pharmacometabolomics by NMR in Oncology: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
16. Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.The pharmacogenomics journal · 2021
    Review
17. Impact of study design and statistical model in pharmacogenetic studies with gene-treatment interaction.CPT: pharmacometrics & systems pharmacology · 2021
    Article
18. Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population.Pharmacogenomics and personalized medicine · 2021
    Article
19. Physicians' Knowledge and Attitudes Regarding Point-of-Care Pharmacogenetic Testing: A Hospital-Based Cross-Sectional Study.Pharmacogenomics and personalized medicine · 2021
    Article
20. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.Journal of the American College of Clinical Pharmacy : JACCP · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract